Back to News

IQ DILI Affiliate launches trial membership to pharma and biotech companies

IQ DILI Affiliate launches trial membership to pharma and biotech companies

May 21, 2021

The IQ DILI Initiative (www.iqdili.org) is launching a trial membership available to pharma and biotech companies. Trial members will be able to participate in all IQ DILI events, working groups, and meetings for 1 year, with limited access to IQ Consortium events, for only the cost of IQ DILI membership. After 1 year, trial members can join both IQ and IQ DILI to continue participation.

Trial memberships will only be available through the end of 2021. Contact the Secretariat now at info@iqdili.org to learn more.